Edwards Lifesciences Working Capital Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 114.31  1.09  0.94%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Working Capital of Edwards Lifesciences Corporation with missing and latest data points interpolated. Working capital measures the difference between Current Assets and Current Liabilities.
View

1.57 B

            10 Years Trend  
Increasing
Slightly volatile
 Working Capital 
      Timeline 

Edwards Lifesciences Working Capital Over Time

2015-12-31  1,571,700,000 
2016-12-31  1,707,500,000 
2017-12-31  1,571,700,000 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  987,875,000
Geometric Mean  752,630,833
Coefficient Of Variation  60.87
Mean Deviation  516,120,833
Median  944,500,000
Standard Deviation  601,349,903
Range  1,697,600,000
R Value  0.96
R Squared  0.92
Significance  0.00000077
Slope  160,087,762

Currently Trending

GOOG   
 NMS 
Purchased few shares of
few hours ago ago
Traded for 1040.48
F   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 12.6
TWTR   
 NYQ 
Purchased over 100 shares of
few hours ago ago
Traded for 21.65